ArticleCancer cell2020

Isotype Switching Converts Anti-CD40 Antagonism to Agonism to Elicit Potent Antitumor Activity.

Xiaojie Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.